source
- Celcuity's Revtorpyk receives FDA approval, but launch delay pushes stock lowerThe FDA announced approval of Celcuity’s oncology candidate Revtorpyk on Tuesday, marking the company’s first cancer drug clearance. Analysts had broadly expected the approval and had priced the s…
- India’s life-sciences sector faces scaling hurdles despite rapid innovation growth, report saysIndia’s life‑sciences sector has shown rapid growth, according to a new report by Boston Consulting Group and HealthKois. Patent filings have risen more than four‑fold since 2016, the pipeline of i…